Digital DBT for Youth at Risk of Psychosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial will randomize CHR youth to receive a digital DBT program or treatment as usual for eight weeks. It aims to assess how feasible and acceptable the digital intervention is, and to gather preliminary data on its effects on emotional regulation, mood symptoms, substance use, and functioning. The approach uses interactive, skill-building modules focused on emotional regulation, distress tolerance, mindfulness, and related areas. Primary outcomes focus on feasibility, acceptability, and usability, while secondary outcomes look at clinical symptoms and functioning to inform future larger trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Be 14-35 years old.
2. Being competent and willing to consent to study participation.
3. Meets CHR criteria for a psychosis risk syndrome based on the Structured Interview for Psychosis Risk Syndromes (SIPS) within the past 3 years.

Exclusion Criteria:

1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosis of psychotic disorder (e.g., schizophrenia spectrum disorder, mood disorder with psychotic features)
2. Diagnosis of intellectual disability
3. Severe developmental disorder
4. Acute suicidality requiring immediate life-saving intervention (i.e., inpatient psychiatric care).
5. Receiving any additional psychotherapy interventions or structured digital mental health support during the study period.

Where it's running

• Centre for Addiction and Mental Health
  Toronto, Ontario, Canada Recruiting

Study contacts

• Principal investigator: M. Omair Husain, MBBS, MRCPsych — The Centre for Addiction and Mental Health (CAMH)
• Study coordinator: M. Omair Husain, MBBS, MRCPsych
• Email: omair.husain@camh.ca
• Phone: 416-535-8501

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Accelerated Brain Stimulation for Young People at Risk of Psychosis

  This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.

  Recruiting Douglas Mental Health University Institute · Verdun, Quebec · NCT07786714

• Recovery-oriented suicide prevention for young people at clinical high risk for psychosis

  This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.

  Recruiting at 2 sites University of California, San Diego · Los Angeles, California and 1 other locations · NCT07756567

• Mindfulness group experiences for young people at high risk for or early in psychosis

  This project tries to understand how group mindfulness sessions feel for French-speaking young people aged 15–30 who are at ultra‑high risk for psychosis or have had a first episode.

  Recruiting at 2 sites Centre Psychothérapique de Nancy · Laxou and 1 other locations · NCT07499934

• Biomarker changes after MT1988 dosing in young people at high risk for psychosis

  This will test whether two doses of MT1988 taken twice daily for 8 weeks change biomarker tests in 17–30-year-olds at high risk for psychosis compared with placebo.

  Recruiting at 15 sites Phase 1/2 Monument Therapeutics Limited · Irvine, California and 14 other locations · NCT07226895

• French version of the Schizophrenia Proneness Instrument for children and adolescents (SPI-CY)

  This project will test the French SPI-CY to see if it reliably identifies French-speaking adolescents (ages 12–17) who are at high risk for developing psychosis.

  Recruiting at 2 sites Centre Psychothérapique de Nancy · Lille and 2 other locations · NCT06649552

• Cognitive training and enhanced treatment for youth at high risk of psychosis in Tunisia

  This study is testing two different treatment approaches to see if they can help young people at high risk for psychosis improve their daily functioning over 12 weeks.

  Recruiting University of California, Los Angeles · Tunis · NCT06582901

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.